Related Experiment Videos
Left ventricular mass as an indicator of hemodynamic load in hypertension
R B Devereux1, G de Simone, A Ganau
1Department of Medicine, Cornell University Medical Center, New York, New York 10021.
Journal of Cardiovascular Pharmacology
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Fructose and salt induce sex- and ovary dependent cardiac hypertrophy in Dahl salt-sensitive rats.
Frontiers in cardiovascular medicine·2026
Cross-linked carboxymethyl cellulose and silk proteins for dry eye disease management and corneal wound healing: in vivo and in vitro results.
European review for medical and pharmacological sciences·2026
Dissection of Nitric Oxide binding pathway in Nitrobindins reveals hidden structural details.
International journal of biological macromolecules·2025
Rankl genetic deficiency and functional blockade undermine skeletal stem and progenitor cell differentiation.
Stem cell research & therapy·2024
Home mobile radiography service in the COVID-19 era.
European review for medical and pharmacological sciences·2021
Sterile carbon particle suspension vs India ink for endoscopic tattooing of colonic lesions: a randomized controlled trial.
Techniques in coloproctology·2019
Statins In Dialysis-Dependent End-Stage Renal Disease: Reconciling Discordant Evidence Through GRADE-Informed Appraisal and Evidence-to-Decision Framework.
Journal of cardiovascular pharmacology·2026
Triple Antithrombotic Therapy for the Prevention of Left Ventricular Thrombus Following Anterior ST-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.
Journal of cardiovascular pharmacology·2026
Eplerenone Revisited: A Balanced Reappraisal of Its Role in Hypertension, Heart Failure, and Cardiorenal Disease.
Journal of cardiovascular pharmacology·2026
Targeting IL-1 in SLE-Associated Recurrent Pericarditis: A Case Series and Review of Mechanistic Rationale.
Journal of cardiovascular pharmacology·2026
Cardiovascular and Thromboembolic Risk With Upadacitinib in Spondyloarthritis and Inflammatory Bowel Disease: A Meta-Analysis of Randomized Controlled Trials.
Journal of cardiovascular pharmacology·2026
Empagliflozin Reduces Post-Myocardial Infarction Inflammation via BDH1/β-Hydroxybutyrate-Mediated NF-κB Modulation in Macrophages and the Heart.
Journal of cardiovascular pharmacology·2026